NOX1 and inflammatory bowel disease: The remaining NOX1 activity of male VEO-IBD patients harboring the missense mutations NOX1 p. N122H and NOX1 p. T497A, or the stop-gain mutation NOX1 p.54R>* is likely negligible or absent [8,10].